Objective: We evaluated the ability of genetic and serological testing to diagnose clinically
relevant thrombophilias in young adults with ischemic stroke. Methods: We performed a …

Abstract Background Venous Thrombo-embolism (VTE) is the major preventable cause of
death and disability worldwide. It has the third highest incidence rate of hospital death after …

Arterial and venous atherothrombotic events are finely regulated processes involving a
complex interplay between vulnerable blood, vulnerable vessel, and blood stasis …

Deep vein thrombosis (DVT) is a potentially catastrophic condition because thrombosis, left
untreated, can result in detrimental pulmonary embolism. Yet in the absence of thrombosis …

The genetic burden underlying venous thrombosis (VT) is characterized by a sibling relative
risk of 2.5 and a strong heritability whose estimates varied from 35% to 60% according to …

Four-factor prothrombin complex concentrate (4F-PCC) is the term used to describe a
pathogen-reduced, lyophilized concentrate that contains therapeutic amounts of at least 4 …

Oral anticoagulants (OACs) are commonly used to reduce the risk of venous
thromboembolism and the risk of stroke in patients with atrial fibrillation. Endorsed by the …

Thrombophilia testing is frequently performed after an ischemic stroke, particularly when
cryptogenic. However, there is minimal evidence supporting a significant association …

Introduction: Influenza is an acute respiratory infection that usually causes a short-term and
self-limiting illness. However, in high-risk populations, this can lead to several complications …

Introduction Venous thromboembolism incidence rates are 30%-100% higher in US blacks
than whites. We examined the degree to which differences in the frequencies of …